Treatments

On this page

• Please note that as of April 2023, this website is no longer actively being updated.
• COVID-19 Guidelines Dashboard
• Overview by Severity
• Oral Antiviral Outpatient Test-to-Treat Algorithm
• Corticosteroids
• Recommendations
• Dosing
• Antivirals
• Remdesivir
• Nirmatrelvir/ritonavir
• Molnupiravir
• Other Antivirals
• Antibodies
• Monoclonal Antibodies
• Convalescent Plasma
• Immunomodulators
• Anti-IL-6 Agents (e.g. Tocilizumab)
• JAK Inhibitors (e.g. Baricitinib)
• Anti-IL-1 Agents (e.g. Anakinra)
• Symptomatic Treatments
• Cough
• Dyspnea
• Pain
• Anxiety
• Respiratory Secretions
• Nausea and Vomiting
• Delirium
• Anticoagulation
• Prophylactic Dosing
• Therapeutic Dosing
• Aspirin
• Antibiotics
• Choice of Antibiotics
• Treatments for Comorbid Diseases
• RAAS Inhibitors
• Statins
• Calcium Channel Blockers
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Bronchodilators
• Inhaled Corticosteroids
• Blood Products
• Immunosuppressants
• Other Miscellaneous Agents
• Hydroxychloroquine
• Azithromycin
• Ivermectin
• Nitazoxanide
• Famotidine
• Vitamins & Minerals
• Zinc
• Vitamin C
• Clinical Trials
• Baseline Immunosuppression
• COVID-19 Risk by Medication
• Management of Baseline Immunosuppression